Inventor · disambiguated record
Stephen Michael Burleigh
Also filed as: BURLEIGH STEPHEN · BURLEIGH STEPHEN MICHAEL
2 granted patents·8 pending applications·1 citations·filing 2018–2022
31Inventor score
Top patents by PatentIndex Score
10 records- 0172US11952408B2HPV-specific binding moleculesJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 9, 2024·1 cites·46 claims
- 0257US2025059538A1COMPOSITIONS AND METHODS OF tRNA SILENCINGSHAPE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0350US2023399635A1RNA-Editing Compositions and Methods of UseSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0449US2024102083A1High throughput rna-editing screening methodsSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0546US2022184131A1Cells expressing a recombinant receptor from a modified tgfbr2 locus, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0643US12435120B2Cells expressing a chimeric receptor from a modified CD247 locus, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2020·Granted Oct 7, 2025·0 cites·16 claims
- 0742US2021015869A1T cells expressing a recombinant receptor, related polynucleotides and methodsJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0842US2021017249A1Methods of producing cells expressing a recombinant receptor and related compositionsJUNO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 0941US2023242910A1Methods and compositions relating to engineered guide systems for adenosine deaminase acting on rna editingSHAPE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1041US2023061455A1Methods, compositions and components for crispr-cas9 editing of tgfbr2 in t cells for immunotherapyEDITAS MEDICINE INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stephen Michael Burleigh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →